| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9852 |
| Human Intestinal Absorption | HIA+ | 0.9898 |
| Caco-2 Permeability | Caco2+ | 0.8078 |
| P-glycoprotein Substrate | Non-substrate | 0.6792 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8912 |
| Non-inhibitor | 0.7550 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9048 |
| Distribution |
| Subcellular localization | Lysosome | 0.4936 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8276 |
| CYP450 2D6 Substrate | Non-substrate | 0.7681 |
| CYP450 3A4 Substrate | Non-substrate | 0.6822 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6579 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9294 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9318 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9447 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9823 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7775 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8953 |
| Non-inhibitor | 0.8127 |
| AMES Toxicity | Non AMES toxic | 0.9912 |
| Carcinogens | Carcinogens | 0.6985 |
| Fish Toxicity | High FHMT | 0.8424 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9706 |
| Honey Bee Toxicity | High HBT | 0.7799 |
| Biodegradation | Ready biodegradable | 0.5915 |
| Acute Oral Toxicity | IV | 0.4727 |
| Carcinogenicity (Three-class) | Non-required | 0.5634 |